
Zynerba Pharmaceuticals (Formerly AllTranz)
Pharmaceutical products via dermal solutions to treat a various neuroscience disorders.
Market cap
$70.1m
Enterprise value
$34m
Share price
$1.30 ZYNE
Authorizing premium user...
Pharmaceutical products via dermal solutions to treat a various neuroscience disorders.